Rajesh Gokhale appointed Secretary, Department of Biotechnology

Dr Gokhale, an immunologist and known for throwing new light on aspects of tuberculosis, was former Director at the CSIR-Institute of Genomics and Integrative Biology

October 26, 2021 11:31 pm | Updated 11:31 pm IST - NEW DELHI

Rajesh Gokhale

Rajesh Gokhale

The Centre has appointed Rajesh Gokhale, 54, as Secretary, Department of Biotechnology, according to a note from the Appointments Committee of the Cabinet on Tuesday. Mr. Gokhale takes over from Renu Swarup, who is set to retire on 31st of this month.

Dr Gokhale, an immunologist and known for throwing new light on aspects of tuberculosis, was former Director at the CSIR-Institute of Genomics and Integrative Biology (IGIB). He is now Professor, Indian Institute of Science Education and Research, Pune and until recently was a senior scientist at the National Institute of Immunology, Delhi.

“It is a big responsibility and I look forward to doing my best,” Mr. Gokhale told The Hindu .

The DBT is a department that has played a crucial role during the pandemic particularly the development of indigenous vaccines.

Mr. Gokhale won the Infosys Life Sciences award, 2013, and was among the few scientists at the CSIR who founded a startup biotech company, following a change in policy in CSIR rules permitting scientists to take stake in startups.

This however took a turn for the worse with a departmental inquiry, a few years on, on alleged ‘conflict of interest’ in his position as a director of a CSIR lab and a scientist with a founder-stake in a company. This prompted enquiries by the Central Vigilance Commission (CVC) and though several expert committees cleared him, it was only in December, 2020 that the matter was finally laid to rest after a Delhi High Court order.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.